Gm Advisory Group, Inc. Moderna, Inc. Transaction History

Gm Advisory Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $6,783 - $9,851	-50 Reduced 2.97%	1,631 $250,000
Q4 2022 Feb 13, 2023	BUY	$118.38 - $210.04 $198,996 - $353,077	1,681 New	1,681 $301,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $193,264 - $291,373	1,650 New	1,650 $236,000
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $153,395 - $285,115	-1,213 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $9,032 - $14,740	-40 Reduced 3.19%	1,213 $308,000
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $110,033 - $199,028	-847 Reduced 40.33%	1,253 $294,000
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $138,054 - $356,706	2,100 New	2,100 $219,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Gm Advisory Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Gm Advisory Group, Inc. with notifications on news.